Paragraph 7 Additional information to be included with routine applications
United Kingdom
If an applicant (A) is making a routine application and is seeking to satisfy F1NHS England that granting that application would meet a need for pharmaceutical services, or secure improvements to or better access to pharmaceutical services, in circumstances where—
that need, those improvements or that better access has or have been identified in the pharmaceutical needs assessment of the relevant HWB (or Primary Care Trust), A must include in that application details that explain how A intends to meet that need, or secure those improvements or that better access (in whole or in part); or
that need, those improvements or that better access has or have not been identified in the pharmaceutical needs assessment of the relevant HWB (or Primary Care F2Trust), A must include in that application, details that explain A's belief that regulation 18(1)(b) is satisfied in relation to that application.
Where an applicant includes information in an application pursuant to paragraph (a) but not paragraph (b) of sub-paragraph (1), NHS England must not consider whether regulation 18(1)(b) applies in relation to that application when it determines that application.
Annotations
Textual amendments
- F1
Words in Regulations substituted (6.11.2023) by The Health and Care Act 2022 (Further Consequential Amendments) (No. 2) Regulations 2023 (S.I. 2023/1071), reg. 1(1), Sch. para. 1
- F2
Word in Sch. 2 para. 7(1)(b) substituted (1.4.2014) by The National Health Service (Pharmaceutical and Local Pharmaceutical Services) (Amendment and Transitional Provision) Regulations 2014 (S.I. 2014/417), regs. 1, 17(a)